Latest White Papers
Best Practices in Molecular Assay Validation for Laboratory-Developed Tests
This comprehensive white paper is designed to be your go-to guide, providing invaluable insights into critical success factors and essential functions crucial for maintaining compliance and delivering reliable results. Tailored for clinical molecular laboratory staff, this resource delves into the tangible aspects of compliant method validation, offering practical strategies for proving the accuracy and efficacy of laboratory-developed tests (LDTs).
Point of Care Testing for Infectious Diseases: Navigating CLIA Compliance and Ensuring Quality
This white paper serves as a practical guide to enhance the understanding of the POCT team regarding critical success factors and essential functions needed to sustain compliance and produce reliable results. It focuses on the tangible aspects of good laboratory practice and regulatory compliance in routine and urgent patient care settings. This resource will be particularly beneficial to nursing and other clinical staff involved in patient testing.
Virus Surveillance: Empowering Communities Through Early Genotypic Testing for HIV Drug Resistance
Covering genotypic testing for drug-resistant mutations, virus cluster detection and response, and programs in action, this free white paper is for health laboratory directors interested in reducing the impact of HIV drug resistance.
Special Report: The Benefits of Lean Six Sigma Training Specifically for Labs
This special report provides an overview of Lean Six Sigma concepts and illustrates how the model serves as a useful ally for labs in the current clinical diagnostic environment. Organizations that adopt the Lean Six Sigma methodology learn how to reduce waste, cut costs, improve quality and enhance outcomes.
Portrait of a Microbiology Lab: Implementing Total Laboratory Automation in a Limited-Resource Environment
This free white paper details the factors that were critical to success of the TLA project and describes how automation helped redefine the clinical value of the hospital’s microbiology laboratory. You’ll learn about how the microbiology TLA conversion unfolded, the lab team involved to handle the project and the issues the team faced to get the job done.
The Case of the Missing Mole: When costly Lost or Missing Laboratory Test Samples Instigate Courier Management Redesign
Incidents of lost or missing laboratory test samples carry heavy consequences. Yet, many laboratories find that accountability, reconciliation, and tracking persist as issues. This white paper will be useful for laboratory directors, lab managers, courier managers, logistics managers, and outreach managers—whether in hospital-based laboratories or independent medical laboratories working as outreach labs—who employ and manage couriers in-house.
Latest E-Briefings
Former FDA Director to Speak at Executive War College on FDA’s Coming Regulation of Laboratory Developed Tests
Tim Stenzel, MD, PhD, will discuss what clinical laboratories need to know about the draft LDT rule, FDA memo on assay reclassification, and ISO-13485 harmonization Many clinical laboratories anxiously await a final rule from the US Food and Drug Administration (FDA)...
Swiss Research Study into Long COVID Promises New Diagnostic and Therapeutic Possibilities
New biomarker may lead to new clinical laboratory testing and treatments for long COVID Researchers studying long COVID at the University Hospital of Zurich (UZH) and the Swiss Institute of Bioinformatics (SIB), both in Switzerland, have discovered a protein biomarker...
Scientists at UT Health San Antonio Discover New Biomarker for Diabetic Kidney Disease
Biomarker may lead to clinical laboratory testing that enables clinical pathologists and urologists to diagnose risk for diabetic kidney failure years before it occurs Clinical laboratories working with nephrologists and urologists to diagnose patients experiencing...
Rice University Researchers Develop ‘Molecular Jackhammer’ That Kills Cancer Cells
Research could lead to similar treatments for other diseases, as well as creating a demand for a new line of oncology tests for clinical labs and pathology groups Cancer treatment has come a long way in the past decades, and it seems poised to take another leap...
Private Equity Firm General Catalyst to Buy Integrated Delivery Network Summa Health as Testing Ground for New Venture
Switching from non-profit to for-profit may affect how clinical laboratories operate in the new healthcare system Shifting away from fee-for-service payment models and towards value-based healthcare is the goal of many non-profit hospital systems. One such...
San Diego University Researchers Believe Bacteriophages May Be the Future of Eradicating Multi-Drug Resistant Superbugs
Clinical laboratories and microbiologists may soon have new powerful tools for fighting antimicrobial resistant bacteria that saves lives Superbugs—microbes that have developed multidrug resistance—continue to cause problems for clinical laboratories and hospital...
Perfect Storm of Clinical Lab and Pathology Practice Regulatory Changes to Be Featured in Discussions at 29th Annual Executive War College
Forces in play will directly impact the operations and financial stability of many of the nation’s clinical laboratories With significant regulatory changes expected in the next 18 to 24 months, experts are predicting a “Perfect Storm” for managers of clinical...
Increased Testing Demands from Physicians is Putting New Zealand Clinical Laboratories Under Severe Stress
Following the loss of its histology accreditation, pressure on APS laboratory continues to mount Government-run healthcare systems around the world often under-invest as demand grows and new healthcare technologies enter clinical practice. One such example is taking...
AXIM Biotechnologies Develops Diagnostic Test for Parkinson’s Disease That Uses Tear Drop Specimens and Returns Results in Less than 10 Minutes at the Point of Care
New non-invasive test could replace traditional painful spinal taps and clinical laboratory fluid analysis for diagnosis of Parkinson’s disease Scientists at AXIM Biotechnologies of San Diego have added another specimen that can be collected non-invasively for rapid,...
Scientists Close in on Elusive Goal of Adapting Nanopore Technology for Protein Sequencing
Technology could enable medical laboratories to deploy inexpensive protein sequencing with a handheld device at point of care and remote locations Clinical laboratories engaged in protein testing will be interested in several recent studies that suggest scientists may...
Upcoming Webinars
FREE WEBINAR
STIs and Resistant Organisms: Causes, Prevalence, Treatments
and Tests
Airing April 10, 2024
FREE WEBINAR
Maximizing Financial Outcomes: Data-Driven Strategies for RCM Workflow Prioritization
Airing April 17, 2024
Latest Webinars
FREE WEBINAR
Reimbursement Strategies for Denials Management: To Appeal or Not to Appeal?
Aired on March 27, 2024
FREE WEBINAR
The Triple Threat: Has it changed since the last respiratory season?
Aired February 28, 2024
FREE WEBINAR
New Solutions in Laboratory Supply and Logistics Management that Cut Costs, Improve Compliance, and Boost Revenue
Aired February 21, 2024
PREMIUM WEBINAR
SPECIAL REPORT Premium Webinar: Essential Guide to Obtaining Z-Codes for Molecular and Genetic Tests
Aired June 29, 2023
FREE WEBINAR
From Market Access Through Reimbursement: Your Playbook to Maximize Revenue and Cash Flow
Aired December 12, 2023
FREE WEBINAR
Best Practices in Molecular Assay Validation for Laboratory-Developed Tests
Aired November 8, 2023
CLIA INSPECTION READY
SPECIAL REPORT | Better CLIA Compliance: Reviewing Top Deficiencies from Accreditors and Looking to Future CLIA Reform
Store
-
SPECIAL REPORT | Better CLIA Compliance: Reviewing Top Deficiencies from Accreditors and Looking to Future CLIA Reform
$129.00 -
SPECIAL REPORT Premium Webinar: Essential Guide to Obtaining Z-Codes for Molecular and Genetic Tests
$195.00 -
Executive War College 2023 – Audio Recordings
$599.00 -
DARK DAILY Webinar: What Lab Leaders Need to Know: Data Security Agreements, Surprise Billing, EKRA, AKS, CURES Act, and More
$195.00 -
SPECIAL REPORT: State of the Genetic Testing Marketplace
$195.00